Declaration of Voting Result and Scrutinizer Report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Limited held an Extra Ordinary General Meeting on July 23, 2025, where shareholders approved a Special Resolution to issue up to 91,02,000 Convertible Equity Share Warrants at ₹42.25 each (including a ₹32.25 premium), aggregating up to ₹38.46 crore. The warrants will be allotted on a preferential/private placement basis to members of the Promoter Group and Non-Promoters, with an option to convert each warrant into one equity share. Of the 1,121 shareholders on record date, 63,54,000 votes were polled (54.97% of outstanding shares), with 100% voting in favour and zero against. Promoters (interested party) voted their entire 60,48,000 shares in favour, while public non-institutions polled 3,09,000 votes, all in favour.
Shareholders have approved a preferential warrant issue worth ₹38.46 crore, which will lead to equity dilution once warrants are converted but also brings fresh capital into the company. Since promoters are participating in the issue, it signals promoter confidence, though existing public shareholders will see their stake reduced.